Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | EIF4EBP1 | Q13541 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | CCR2 | P41597 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29521552 | 1.00 | L3MBTL1 (0.36) | L3MBTL1EIF4EBP1LMNAMEN1KMT2A | |
| SCHEMBL20465926 | 0.90 | ALDH1A1 (0.32) | L3MBTL1EIF4EBP1LMNAMEN1KMT2A | |
| SCHEMBL20468290 | 0.89 | ALDH1A1 (0.32) | L3MBTL1EIF4EBP1LMNAMEN1KMT2A | |
| SCHEMBL29521322 | 0.89 | ALDH1A1 (0.32) | L3MBTL1EIF4EBP1LMNAMEN1KMT2A | |
| SCHEMBL29521282 | 0.87 | L3MBTL1 (0.34) | L3MBTL1LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL20465844 | 0.87 | L3MBTL1 (0.34) | L3MBTL1LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL20455826 | 0.85 | L3MBTL1 (0.33) | L3MBTL1LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL29521298 | 0.85 | L3MBTL1 (0.33) | L3MBTL1LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL20468293 | 0.82 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL29521486 | 0.82 | DDR1 (0.35) | L3MBTL1EIF4EBP1LMNACCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110248941-B | Aryl-or heteroaryl-substituted imidazopyridine derivatives and their use as pesticides | 拜耳公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-110248942-B | Process for preparing halogenated imidazopyridine derivatives | 拜耳公司 | 2022-04-19 | — | — | CN | disclosed |
| EP-3577114-B1 | METHOD FOR THE PREPARATION OF HALOGENATED IMIDAZOPYRIDINE DERIVATIVES | BAYER AG (DE) | 2021-11-10 | — | — | EP | disclosed |
| EP-3577114-B1 | METHOD FOR THE PREPARATION OF HALOGENATED IMIDAZOPYRIDINE DERIVATIVES | BAYER AG (DE) | 2021-11-10 | — | — | EP | disclosed |
| US-11072609-B2 | Method for preparing halogenated imidazopyridine derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2021-07-27 | — | — | US | disclosed |
| US-11072609-B2 | Method for preparing halogenated imidazopyridine derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2021-07-27 | — | — | US | disclosed |
| US-20210094947-A1 | METHOD FOR PREPARING HALOGENATED IMIDAZOPYRIDINE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2021-04-01 | — | — | US | disclosed |
| US-20210094947-A1 | METHOD FOR PREPARING HALOGENATED IMIDAZOPYRIDINE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2021-04-01 | — | — | US | disclosed |
| US-10772332-B2 | 2-(het)aryl-substituted fused heterocycle derivatives as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2020-09-15 | — | — | US | disclosed |
| US-10772332-B2 | 2-(het)aryl-substituted fused heterocycle derivatives as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2020-09-15 | — | — | US | disclosed |
| US-20200236940-A1 | 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-07-30 | — | — | US | disclosed |
| US-20200236940-A1 | 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-07-30 | — | — | US | disclosed |
| WO-2018141954-A1 | ARYL OR HETEROARYL-SUBSTITUTED IMIDAZO PYRIDINE DERIVATIVES AND THEIR USE AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2018-08-09 | — | — | WO | disclosed |
| WO-2018141955-A1 | PROCESS FOR PREPARING HALOGENATED IMIDAZOPYRIDINE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2018-08-09 | — | — | WO | disclosed |
| WO-2018141954-A1 | ARYL OR HETEROARYL-SUBSTITUTED IMIDAZO PYRIDINE DERIVATIVES AND THEIR USE AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2018-08-09 | — | — | WO | disclosed |
| WO-2018141955-A1 | PROCESS FOR PREPARING HALOGENATED IMIDAZOPYRIDINE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2018-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10772332-B2 | 2-(het)aryl-substituted fused heterocycle derivatives as pesticides | CYP4X1, CYP1A1, CYP1A2 | L3MBTL1 896/4885EIF4EBP1 3067/4885LMNA 1094/4885 |
| US-20210094947-A1 | METHOD FOR PREPARING HALOGENATED IMIDAZOPYRIDINE DERIVATIVES | CYP2F1, CYP2D6, POLR2A | L3MBTL1 3330/4885EIF4EBP1 1114/4885LMNA 1284/4885 |
| US-11072609-B2 | Method for preparing halogenated imidazopyridine derivatives | CYP2F1, CYP2D6, POLR2A | L3MBTL1 3330/4885EIF4EBP1 1114/4885LMNA 1284/4885 |
| US-20200236940-A1 | 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES | CYP4X1, CYP1A1, CYP1A2 | L3MBTL1 896/4885EIF4EBP1 3067/4885LMNA 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.